+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Molecular Forensics Market: Focus on Product, Technology Application, End User, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

  • ID: 4856581
  • Report
  • November 2019
  • Region: Global
  • 184 Pages
  • BIS Research
1 of 6
Global Gallium Nitride Market Anticipated to Reach $461.0 million by 2029

FEATURED COMPANIES

  • Analytik Jena AG
  • BioChain Institute Inc.
  • Eurofins Scientific SE
  • General Electric Company
  • Illumina, Inc.
  • LGC Limited
  • MORE

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global molecular forensics market?
  • What are the underlying structures resulting in the emerging trends within the global molecular forensics market?
  • How is each segment of the global molecular forensics market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global molecular forensics market? What are the major segments of these applications?
  • Who are the key manufacturers in the global molecular forensics market, and what are their contributions?

Global Molecular Forensics Market Forecast, 2019-2029

The molecular forensics industry analysis projects the market to grow at a significant CAGR of 9.09% during the forecast period, 2019-2029. The molecular forensics market generated $996.9 million in revenue in 2018, in terms of value.

The molecular forensics market growth has been primarily attributed to the major drivers in this market such as technological advancement, adoption of advanced hybridization technologies for molecular forensics tests, steady investment, and consolidation in the market and favorable regulatory environment. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of methods and techniques and complexity of the techniques.

Expert Quote

“The development field has achieved huge success over the past year with regulatory approval of test in the U.S., Europe, Japan and Australia proving the potential these tests have to successful identification of people around the globe.”

Scope of the Market Intelligence on Molecular Forensics Market

The molecular forensics research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the diagnostic market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global molecular forensics market.

Market Segmentation

  • The molecular forensics market segmentation (on the basis of manufacturing) is further segmented into application, product, technology and end user.
  • The molecular forensics market segmentation (on the basis of application) is segmented into radioactive toxicology, nucleic acid analysis, forensic databasing, microbial forensics, and other applications.
  • The molecular forensics market segmentation (on the basis of product) is segmented into kits and consumables, instruments, and software.
  • The molecular forensics market segmentation (on the basis of technology) is segmented into PCR, NGS, mass spectrometry, and capillary electrophoresis.

Key Companies in the Molecular Forensics Market

The key manufacturers who have been contributing significantly to the molecular forensics market include Agilent Technologies, Inc., Illumina, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., Promega Corporation, Eurofins Scientific SE, General Electric Company, Merck KGaA, LGC Limited, and Thermo Fisher Scientific Inc. among others.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Analytik Jena AG
  • BioChain Institute Inc.
  • Eurofins Scientific SE
  • General Electric Company
  • Illumina, Inc.
  • LGC Limited
  • MORE

Executive Summary

1 Research Scope and Methodology
1.1 Scope of the Study
1.2 Research Methodology
1.3 Data Sources
1.4 Assumptions and Limitations
1.5 Data and Prediction Modeling

2 Market Overview
2.1 Introduction
2.2 Molecular Forensics Technologies and Applications
2.3 Market Available for Molecular Forensics
2.4 Molecular Forensics Technology Trends
2.5 Regulations and Compliances

3 Competitive Landscape
3.1 Mergers and Acquisitions
3.2 Product Launches and Product Updates
3.3 Synergistic Activities
3.4 Business Expansion Activities and Others

4 Market Dynamics
4.1 Overview
4.2 Impact Analysis
4.3 Market Drivers
4.3.1 Augmentation in the Incidences of Crime
4.3.2 Growth in the Biomarker Identification Market and Advancements in Molecular Forensics Techniques
4.3.3 Technological Advancements in the Field of Computational Biology
4.3.4 Significant External Funding for Executing Research and Development Exercises
4.4 Market Restraints
4.4.1 Lack of High Complexity Testing Centers
4.4.2 Expensive Sequencing Procedures and Their Applications in Medical Treatments
4.4.3 High Capital Requirement Hampering the Expansion of Global Reach
4.5 Market Opportunities
4.5.1 Massive Scope for Adoption of NGS and Capillary Electrophoresis in Emerging Nations
4.5.2 Technological Advancements in Molecular Techniques and Diagnostic Tests
4.5.3 Hybridization of Technologies

5 Global Molecular Forensics Market (By Product)
5.1 Overview
5.2 Kits and Consumables
5.3 Instruments
5.4 Software and Other Products

6 Global Molecular Forensics Market (By Technology)
6.1 Overview
6.2 Polymerase Chain Reaction (PCR)
6.2.1 Real-time PCR (q-PCR)
6.2.2 Digital PCR (d-PCR)
6.3 Capillary Electrophoresis
6.4 NGS
6.4.1 SNP and STR Sequencing
6.4.2 mtDNA Sequencing
6.5 Mass Spectrometry
6.5.1 MS
6.5.2 Tandem MS
6.5.3 MS-FTIR
6.6 Other Technologies

7 Global Molecular Forensics Market (By Application)
7.1 Overview
7.2 Radioactive Toxicology
7.3 Nucleic Acid Analysis
7.4 Forensic Databasing
7.5 Microbial Forensics
7.6 Other Applications

8 Global Molecular Forensics Market, By End User
8.1 Overview
8.2 Law Enforcement
8.3 Disaster Management
8.4 Hospitals and Healthcare Providers
8.5 Other End Users

9 Global Molecular Forensics Market, By Region
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.3.7 Russia
9.3.8 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 Australia
9.4.4 India
9.4.5 Singapore
9.4.6 Rest-of-APAC
9.5   Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World

10 Company Profiles
10.1 Overview
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Role of Agilent Technologies, Inc. in the Global Molecular Forensics Market
10.2.3 Financials
10.2.3.1 Key Insights about Financial Health of the Company
10.2.4 SWOT Analysis
10.3 Analytik Jena AG
10.3.1 Company Overview
10.3.2 Role of Analytik Jena AG in the Global Molecular Forensics Market
10.3.3 SWOT Analysis
10.4 AS ONE International, Inc.
10.4.1 Company Overview
10.4.2 Role of AS ONE International, Inc. in the Global Molecular Forensics Market
10.4.3 SWOT Analysis
10.5 BioChain Institute Inc.
10.5.1 Company Overview
10.5.2 Role of BioChain Institute Inc., in the Global Molecular Forensics Market
10.5.3 SWOT Analysis
10.6 Bio-Rad Laboratories, Inc.
10.6.1 Company Overview
10.6.2 Role of Bio-Rad Laboratories, Inc. in the Global Molecular Forensics Market
10.6.3 Financials
10.6.3.1 Key Insights about Financial Health of the Company
10.6.4 SWOT Analysis
10.7 Eurofins Scientific SE
10.7.1 Company Overview
10.7.2 Role of Eurofins Scientific SE in the Global Molecular Forensics Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 General Electric Company
10.8.1 Company Overview
10.8.2 Role of General Electric Company in the Global Molecular Forensics Market
10.8.3 Financials
10.8.3.1 Key Insights about Financial Health of the Company
10.8.4 SWOT Analysis
10.9 Illumina, Inc.
10.9.1 Company Overview
10.9.2 Role of Illumina, Inc. in the Global Molecular Forensics Market
10.9.3 Financials
10.9.3.1 Key Insights about Financial Health of the Company
10.9.4 SWOT Analysis
10.10   LGC Limited
10.10.1 Company Overview
10.10.2 Role of LGC Limited in the Global Molecular Forensics Market
10.10.3 Financials
10.10.3.1 Key Insights about Financial Health of the Company
10.10.4 SWOT Analysis
10.11   MACHEREY-NAGEL GmbH & Co KG
10.11.1 Company Overview
10.11.2 Role of MACHEREY-NAGEL GmbH & Co KG in the Global Molecular Forensics Market
10.11.3 SWOT Analysis
10.12   Merck KGaA
10.12.1 Company Overview
10.12.2 Role of Merck KGaA in the Global Molecular Forensics Market
10.12.3 Financials
10.12.3.1 Key Insights about Financial Health of the Company
10.12.4 SWOT Analysis
10.13   Promega Corporation
10.13.1 Company Overview
10.13.2 Role of Promega Corporation in the Global Molecular Forensics Market
10.13.3 SWOT Analysis
10.14   QIAGEN N.V.
10.14.1 Company Overview
10.14.2 Role of QIAGEN N.V. in the Global Molecular Forensics Market
10.14.3 Financials
10.14.3.1 Key Insights about Financial Health of the Company
10.14.4 SWOT Analysis
10.15   Thermo Fisher Scientific Inc.
10.15.1 Company Overview
10.15.2 Role of Thermo Fisher Scientific Inc. in the Global Molecular Forensics Market
10.15.3 Financials
10.15.3.1 Key Insights about Financial Health of the Company
10.15.4 SWOT Analysis
10.16  Verogen, Inc.
10.16.1 Company Overview
10.16.2 Role of Verogen, Inc. in the Global Molecular Forensics Market
10.16.3 SWOT Analysis

List of Tables
Table 2.1: Regulatory Bodies

List of Figures
Figure 1: Impact of Market Drivers and Market Restraints on the Global Molecular Forensics Market
Figure 2: Global Molecular Forensics Market Snapshot, 2018 and 2029 ($Million)
Figure 3: Dominating Segments of the Global Molecular Forensics Market, 2018 and 2029
Figure 4: Global Molecular Forensics Market (by Application), 2018 and 2029
Figure 5: Global Molecular Forensics Market (by Product), 2018 and 2028
Figure 6: Global Molecular Forensics Market (by End User), 2018 and 2028
Figure 7: Global Molecular Forensics Market (by Region), 2018 and 2029
Figure 1.1: Global Molecular Forensics Market Segmentation
Figure 1.2: Global Molecular Forensics Market Research Methodology
Figure 1.3: Primary Research
Figure 1.4: Secondary Research
Figure 1.5: Data Triangulation
Figure 1.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 1.7: Top-Down Approach (Segment-Wise Analysis)
Figure 1.8: Assumptions and Limitations
Figure 1.9: Considered Factors for Data Prediction and Modeling
Figure 2.1: Different steps in Molecular Forensics Technology
Figure 3.1: Share of Key Developments and Strategies, January 2016 – June 2019
Figure 3.2: Product Launches Share (by Company), January 2016 – June 2019
Figure 3.3: Synergistic Activities Share (by Company), January 2016 – June 2019
Figure 3.4: Business Expansion Activities Share (by Company), January 2016 – June 2019
Figure 4.1: Impact Analysis
Figure 5.1: Global Molecular Forensics Market (by Product)
Figure 5.2: General Workflow of a Molecular Forensics Kit
Figure 5.3: Global Molecular Forensics Market (by Kits and Consumables), 2018-2029
Figure 5.4: Global Molecular Forensics Market (by Instruments), 2018-2029
Figure 5.5: Global Molecular Forensics Market (by Software and Other Products), 2018-2029
Figure 6.1: Global Molecular Forensics Market (by Technology)
Figure 6.2: Global Molecular Forensics Market (by Technology), 2017
Figure 6.3: Global Molecular Forensics Market (by PCR), 2018-2029
Figure 6.4: Global Molecular Forensics Market (by Capillary Electrophoresis), 2018-2029
Figure 6.5: Global Molecular Forensics Market (by SNP and STR Sequencing), 2018-2029
Figure 6.6: Global Molecular Forensics Market (by mtDNA Sequencing), 2018-2029
Figure 6.7: Global Molecular Forensics Market (by MS), 2018-2029
Figure 6.8: Global Molecular Forensics Market (by Tandem MS), 2018-2029
Figure 6.9: Global Molecular Forensics Market (by MS-FTIR), 2018-2029
Figure 6.10: Global Molecular Forensics Market (by Other Technologies), 2018-2029
Figure 7.1: Global Molecular Forensics Market (by Application)
Figure 7.2: Global Molecular Forensics Market (by Radioactive Toxicology), 2018-2029
Figure 7.3: Global Molecular Forensics Market (by Nucleic Acid Analysis), 2018-2029
Figure 7.4: Global Molecular Forensics Market (by Forensic Databasing), 2018-2029
Figure 7.5: Global Molecular Forensics Market (by Microbial Forensics), 2018-2029
Figure 7.6: Global Molecular Forensics Market (by Other Applications), 2018-2029
Figure 8.1: Global Molecular Forensics Market (by End User)
Figure 8.2: Global Molecular Forensics Market (by Law Enforcement), 2018-2029
Figure 8.3: Global Molecular Forensics Market (by Disaster Management), 2018-2029
Figure 8.4: Global Molecular Forensics Market (by Hospitals and Healthcare Providers), 2018-2029
Figure 8.5: Global Molecular Forensics Market (by Other End Users), 2018-2029
Figure 9.1: Global Molecular Forensics Market (by Region)
Figure 9.2: Global Molecular Forensics Market (by Region), 2018-2029
Figure 9.3: Global Molecular Forensics Market Share (by Region), 2018
Figure 9.4: Global Molecular Forensics Market Share (by Region), 2029
Figure 9.5: North America Molecular Forensics Market, 2018-2029
Figure 9.6: North America: Market Dynamics
Figure 9.7: North America Molecular Forensics Market (by Country), 2018-2029
Figure 9.8: U.S. Molecular Forensics Market, 2018-2029
Figure 9.9: Canada Molecular Forensics Market, 2018-2029
Figure 9.10: Europe Molecular Forensics Market, 2018-2029
Figure 9.11: Europe: Market Dynamics
Figure 9.12: Europe Molecular Forensics Market (by Country), 2018-2029
Figure 9.13: Germany Molecular Forensics Market, 2018-2029
Figure 9.14: France Molecular Forensics Market, 2018-2029
Figure 9.15: U.K. Molecular Forensics Market, 2018-2029
Figure 9.16: Italy Molecular Forensics Market, 2018-2029
Figure 9.17: Spain Molecular Forensics Market, 2018-2029
Figure 9.18: Netherlands Molecular Forensics Market, 2018-2029
Figure 9.19: Russia Molecular Forensics Market, 2018-2029
Figure 9.20: Rest-of-Europe Molecular Forensics Market, 2018-2029
Figure 9.21: Asia-Pacific Molecular Forensics Market, 2018-2029
Figure 9.22: APAC: Market Dynamics
Figure 9.23: APAC Molecular Forensics Market (by Country), 2018-2029
Figure 9.24: China Molecular Forensics Market, 2018-2029
Figure 9.25: Japan Molecular Forensics Market, 2018-2029
Figure 9.26: Australia Molecular Forensics Market, 2018-2029
Figure 9.27: India Molecular Forensics Market, 2018-2029
Figure 9.28: Singapore Molecular Forensics Market, 2018-2029
Figure 9.29: RoAPAC Molecular Forensics Market, 2018-2029
Figure 9.30: Latin America Molecular Forensics Test Market, 2018-2029
Figure 9.31: Latin America: Market Dynamics
Figure 9.32: Latin America Molecular Forensics Market (by Country), 2018-2029
Figure 9.33: Brazil Molecular Forensics Market, 2018-2029
Figure 9.34: Mexico Molecular Forensics Market, 2018-2029
Figure 9.35: Rest-of-Latin America Molecular Forensics Market, 2018-2029
Figure 9.36: RoW Molecular Forensics Market, 2018-2029
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: Agilent Technologies, Inc.: Product Portfolio
Figure 10.3: Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 10.4: Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
Figure 10.5: Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 10.6: Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 10.7: Agilent Technologies, Inc.: SWOT Analysis
Figure 10.8: Analytik Jena AG: Product Portfolio
Figure 10.9: Kaneka Eurogentec S.A.: SWOT Analysis
Figure 10.10: AS ONE International, Inc.: Product Portfolio
Figure 10.11: AS ONE International, Inc.: SWOT Analysis
Figure 10.12: BioChain Institute Inc.: Overall Product Portfolio
Figure 10.13: BioChain Institute Inc.: SWOT Analysis
Figure 10.14: Bio-Rad Laboratories, Inc.: Product Offerings
Figure 10.15: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 10.16: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2016-2018
Figure 10.17: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 10.18: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
Figure 10.19: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.20: Product Portfolio: Eurofins Scientific SE
Figure 10.21: Eurofins Scientific SE: Overall Financials, 2016-2018
Figure 10.22: Eurofins Scientific SE: Revenue (by Region), 2016-2018
Figure 10.23: Eurofins Scientific SE.: SWOT Analysis
Figure 10.24: GE Healthcare: Product Portfolio
Figure 10.25: General Electric Company: Overall Financials, 2016-2018
Figure 10.26: General Electric Company: Revenue (by Segment), 2016-2018
Figure 10.27: General Electric Company: Revenue Split for Healthcare, 2016-2018
Figure 10.28: General Electric: Healthcare Revenue (by Region), 2016-2018
Figure 10.29: General Electric Company: R&D Expenditure, 2016-2018
Figure 10.30: General Electric Company: SWOT Analysis
Figure 10.31: Illumina, Inc.: Overall Product Portfolio
Figure 10.32: Illumina, Inc.: Overall Financials, 2016-2018
Figure 10.33: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 10.34: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 10.35: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 10.36: Illumina, Inc.: SWOT Analysis
Figure 10.37: LGC Limited: Overall Financials, 2017-2018
Figure 10.38: LGC Limited: Revenue (by Segment), 2017-2018
Figure 10.39: LGC Limited: Revenue (by Region), 2018
Figure 10.40: LGC Limited: R&D Expenditure, 2017-2018
Figure 10.41: LGC Limited: SWOT Analysis
Figure 10.42: Product Portfolio: LGC Limited
Figure 10.43: MACHERY-NAGEL GmbH & Co KG: SWOT Analysis
Figure 10.44: Merck KGaA: Overall Product Portfolio
Figure 10.45: Merck KGaA: Overall Financials, 2016-2018
Figure 10.46: Merck KGaA: Revenue (by Segment), 2016-2018
Figure 10.47: Merck KGaA: Revenue (by Region), 2016-2018
Figure 10.48: Merck KGaA: R&D Expenditure, 2016-2018
Figure 10.49: Merck KGaA: SWOT Analysis
Figure 10.50: Promega Corporation: Product Portfolio
Figure 10.51: Promega Corporation: SWOT Analysis
Figure 10.52: QIAGEN N.V.: Product Portfolio
Figure 10.53: QIAGEN N.V.: Overall Financials, 2016-2018
Figure 10.54: QIAGEN N.V.: Revenue (by Segment), 2016-2018
Figure 10.55: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 10.56: QIAGEN N.V.: R&D Expenditure, 2016-2018
Figure 10.57: QIAGEN N.V.: SWOT Analysis
Figure 10.58: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.59: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.60: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 10.61: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 10.62: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 10.63: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 10.64: Verogen, Inc.: Overall Product Portfolio
Figure 10.65: Verogen, Inc.: SWOT Analysis

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Analytik Jena AG
  • BioChain Institute Inc.
  • Eurofins Scientific SE
  • General Electric Company
  • Illumina, Inc.
  • LGC Limited
  • MORE

With the completion of the Human Genome Project (HGP), a new wave of technologies, called next-generation sequencing (NGS) was introduced in the healthcare industry. PCR, and NGS have fundamentally changed genomics research and enabled the scientists to research extensively on the gene variants to specific molecular diagnostics and aided the development of targeted therapeutics depending on the genetic profile of an individual. The completion of the project, subsequently, created platform for the development of precision medicines. One of the revolutionary breakthroughs which NGS has resulted in is molecular forensics. Molecular forensics involves a detailed study of individual information to identify and characterize the molecular sequences, resulting in target-based identification. This method approach based on biomarker study is perceived to be promising in driving a paradigm shift in the molecular forensics industry, facilitating the elimination of uncertainty pertaining to the trial-and-error method of medications, and certainly eliminating unnecessary healthcare spending. With sequencing being the primitive pivotal step involved in biomarker study and in the field of genetics, the development of the sequencing technologies played a crucial role in the evolution of molecular forensics.

Further remarkable advancements in the field of genomics, proteomics, molecular biology, data analytics, and technical engineering have paved the way for the development of advanced NGS-based technologies, such as SNP and STR sequencing. The impressive research on molecular technologies and biomarkers using NGS has unlocked pathways for the development of momentous various procedures such as mtDNA sequencing. The growing demand for non-invasive diagnostic procedures enabling genetic profiling has further enhanced the requirement of NGS technologies. Acknowledging the future potential for massive growth in demand for non-invasive diagnostic procedures, several biotechnology companies such as Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies, Inc. have invested substantially to aid further developments in forensics technologies.

According to the latest report titled ‘Global Molecular Forensics Market – Analysis and Forecast (2019-2029)’, the global molecular forensics market has been currently witnessing rapid growth and is expected to continue to grow with a CAGR of 9.09% during the forecast period, 2019-2029.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global molecular forensics market?
  • What are the underlying structures resulting in the emerging trends within the global molecular forensics market?
  • How is each segment of the global molecular forensics market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global molecular forensics market? What are the major segments of these applications?
  • Who are the key manufacturers the global molecular forensics market, and what are their contributions?
Note: Product cover images may vary from those shown
5 of 6
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • AS ONE International, Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • General Electric Company
  • Illumina, Inc.
  • LGC Limited
  • MACHEREY-NAGEL GmbH & Co KG
  • Merck KGaA
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Verogen, Inc.
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll